According to BBC UK, parents of children with cystic fibrosis have resorted to medical tourism to purchase a generic of the CF drug Orkambi (lumacaftor/ivacaftor), which is not available through the National Health Service in the UK.

A generic version [of Orkambi] is being produced in Argentina for £24,000 (~$30,600), as Vertex failed to patent Orkambi there.

That has led to some patients from Hampshire joining a buyers’ club to legally purchase the generic drug, although for most that is not an option.